Trial design in the era of highly effective antiviral drug combinations for HIV infection.
DeGruttola
V
V
Harvard School of Public Health, Department of Biostatistics, Boston, MA 02115, USA.
Hughes
M
M
Gilbert
P
P
Phillips
A
A
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
D019380:Anti-HIV Agents; D012367:RNA, Viral